Asian CROs and R&D cuts

Do you think Asian CROs will grow because of R&D cuts in the pharmaceutical companies of the West?

Current Voting

58%

42%

Survey Box

Ranbaxy Controversy

Will the Ranbaxy controversy end the Indian pharma dominion in the US market?

Send this article by email

X